Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Enterprise Value for 6 consecutive years, with -$70.2 million as the latest value for Q3 2025.
- Quarterly Enterprise Value rose 99.77% to -$70.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$70.2 million through Sep 2025, up 99.77% year-over-year, with the annual reading at -$70.2 million for FY2025, 99.77% up from the prior year.
- Enterprise Value hit -$70.2 million in Q3 2025 for Universe Pharmaceuticals, up from -$30.9 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$21.8 million in Q3 2021 to a low of -$30.9 billion in Q3 2024.
- Historically, Enterprise Value has averaged -$8.4 billion across 5 years, with a median of -$5.3 billion in 2023.
- Biggest five-year swings in Enterprise Value: plummeted 26155.92% in 2022 and later skyrocketed 99.77% in 2025.
- Year by year, Enterprise Value stood at -$21.8 million in 2021, then tumbled by 26155.92% to -$5.7 billion in 2022, then grew by 7.65% to -$5.3 billion in 2023, then plummeted by 484.03% to -$30.9 billion in 2024, then surged by 99.77% to -$70.2 million in 2025.
- Business Quant data shows Enterprise Value for UPC at -$70.2 million in Q3 2025, -$30.9 billion in Q3 2024, and -$5.3 billion in Q3 2023.